跳至主要内容
临床试验/CTRI/2010/091/002817
CTRI/2010/091/002817已完成4 期

Evaluation of efficacy of a test product kit containing 4 test products (Hair Forever SLS Free Shampoo, Hair Forever Growth Enhancer Gel, Hair Forever LLP Free Nourishing & Revitalizing oil and Hair Forever Scalp Essential pack) in men with Androgenetic Alopecia.

TVC Sky Shop Ltd0 个研究点目标入组 35 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Voluntary men suffering from androgenetic alopecia grade 2 vertex, 3 and 4.
  • 2.Age: 18 to 55 years.
  • 3.Not having done any cosmetic hair treatments i.e. coloring, bleaching, and henna, etc for last 1 month.
  • 4.Has been fully informed verbally and in writing to comply with the study specifications.
  • 5.Having signed a Consent Form and will be once informed orally and in writing of all information concerning the study procedures and study objectives.
  • 6.Presenting healthy scalp.
  • 7.Accepting not to use products with same end benefit, during the study.
  • 8.Cooperating, informed of the need and duration of the examinations.
  • 9.For which the investigator considers that the compliance will be correct.

排除标准

  • 1. Cutaneous illness, localized on tested areas, which could interfere with the clinical evaluation.
  • 2. History of allergic dermatitis to cosmetics or hair care products.
  • 3. Subjects taking treatment for hair fall
  • ?local - during last 1month
  • ?or using minoxidil during last 3 months
  • ?and systemic - during last 3 months
  • 4. Subjects on any other local (during last 1month) or systemic (during last 3 months) medical treatment that could interfere with hair growth or hair loss e.g. vasodilators, steroids etc.
  • 5. Haemoglobin less than 10 g/dl by blood test
  • 6. Subjects with history of medical/surgical events that may significantly affect the study outcome e.g. h/o typhoid or jaundice etc.
  • 7. Hyper sensitivity to any component of the tested product,
  • 8. Volunteers exposed to intense sunlight.
  • 9. Any acute or chronic disease.
  • 10. Subject in an exclusion period or participating in another similar cosmetic or therapeutic trial as identified during screening on visit 1 (V1).

研究者

发起方
TVC Sky Shop Ltd

相似试验